Switzerland’s
investment industry industry,
in focus.

Enter MusicBird’s agreement with Dougie Thomson, who’s cashed in on the “master royalty income from” his roughly 16-year run with Supertramp.

The venture firm is now raising a new US$150 million fund to make bets on later-stage startups, with cheque sizes ranging from US$8 million to US$12 million. This fund is also backed by the Schindler family.

Syngenta Group, which belongs to the Chinese state of Sinochem, plans an initial public offer ("IPO") in Hong Kong that can raise up to $10 billion in 2026.

Swiss Merchant Group AG has acquired a 56 percent stake in Helvetic Immobilien AG, marking an important strategic step in expanding its Swiss real estate business.

Swiss pharma giant Roche took over California-based metabolic disease therapeutics company 89bio for $7.3 billion.

UBS Asset Management (Americas) LLC announces that it has entered into a definitive agreement to sell its O’Connor single manager hedge fund, private credit and commodities platform to Cantor Fitzgerald.

The merger between Ina Invest AG and Cham Group AG was successfully completed with yesterday’s entry in the commercial register.

Matador Secondary Private Equity’s fx-adjusted net profit reached CHF1.9m, translating into an FY25 book value (equity) total return (TR) of 3.2% at constant currency (or -9.1% including currency changes, mostly due to the weakening of the US dollar), bringing Matador’s five-year return to 8.6% per year.